Malignant Pheochromocytoma Lacking Clinical Features of Catecholamine Excess Until the Late Stage
スポンサーリンク
概要
- 論文の詳細を見る
A malignant pheochromocytoma is described in a 71-year-old man. Osseous metastases became manifest 12 years after successful removal of the primary tumor which originated in paraganglionic tissue near the right adrenal gland. Although the patient had no symptoms of catecholamine excess initially, hypertension, tachycardia and excessive sweating appeared several months before his death, concomitantly with a sharp increase in noradrenaline secretion due to an accelerated growth of metastatic tumors. Since there is no histologic criterion of malignancy in this neoplasm, it would be prudent to consider every case of pheochromocytoma as potentially malignant and to follow-up carefully for a long time after removal of the primary tumor.(Internal Medicine 39: 820-825, 2000)
- 社団法人 日本内科学会の論文
著者
-
Honda Munehiro
Fourth Department Of Medicine Teikyo University School Of Medicine
-
Dezawa Akira
The Department Of Orthopedic Surgery
-
HONDA Munehiro
the Fourth Department of Medicine
-
UESUGI Kazuto
the Fourth Department of Medicine
-
YAMAZAKI Hiroyuki
the Fourth Department of Medicine
-
MIZOGUCHI Kunio
the Department of Pathology, Teikyo University School of Medicine
-
YAMAJI Tohru
Odawara Hospital, Printing Bureau, Ministry of Finance
-
ISHIBASHI Miyuki
the Fourth Department of Medicine
-
Mizoguchi Kunio
The Department Of Pathology Teikyo University School Of Medicine
-
ISHIBASHI Miyuki
Fourth Department of Medicine, Teikyo University School of Medicine
関連論文
- Primary Hyperparathyroidism Associatiated with Aldosterone-Producing Adrenocortical Adenoma and Breast Cancer : Relation to MEN1 Gene
- Malignant Pheochromocytoma Lacking Clinical Features of Catecholamine Excess Until the Late Stage
- Adrenal Myelolipoma Associated with Congenital Adrenal 21-Hydroxylase Deficiency.
- Acute Liver Dysfunction Complicated with Uncontrollable Glycemia due to Insulin Antibody: Successful Treatment with Glucocorticoid and Lispro Insulin